Hims & Hers, the high-flying online health company that rapidly grew from a buzzy startup selling Viagra to a multibillion-dollar business, had a hard month.

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Wegovy (semaglutide) will no longer be available through Hims & Hers Health, as Novo Nordisk has ended its short-lived partnership.

Hims & Hers Health, Inc. (HIMS) Faces Securities Class Actions After Novo Nordisk Cancels Partnership Over “Deceptive” Marketing of Wegovy– Hagens Berman Provided by GlobeNewswire Jul 2 ...

Hims & Hers is offering Wegovy at $599 per month, with added access to 24/7 care, nutritional guidance, and ongoing clinical support, while Ro is offering it at $499 per month – the same as ...

Companies like Hims & Hers are allowed to offer compounded versions of Ozempic and Wegovy because the brand-name drugs are in shortage and have been for years.